New Zealand’s health regulator Medsafe has approved the paediatric Pfizer vaccine against Covid-19 for children of age 5 to 12 years, the health ministry said in a statement.
- Food Prices Continue to Surge Despite Retail Inflation Eases in April
- Apple and Google partners Up for Bluetooth Devices
- GST Registration Based on Aadhaar Technology Available in Five States
- Piramal Group Subsidiary Announced Plans to Invest Rs 600 Crore in Annapurna Finance
- SEBI Tightens Rules for Listing of Small Businesses
The temporary approval is for two doses of the paediatric Pfizer Covid-19 vaccine, which can be given in at least 21 days break, the statement said. If the cabinet approves the vaccine, the paediatric Pfizer vaccine will be started in New Zealand by the end of January 2022, the health ministry added.